CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea - PR Newswire

/PRNewswire/ -- A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great...

Compound could be game-changer for dangerous pathogen NUTLEY, N.J., Aug. 23, 2022 /PRNewswire/ -- A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Disco… [+5886 chars]

full article...